Machine Learning Times
EXCLUSIVE HIGHLIGHTS
Incoherent AGI Hype Spurs An Industrywide Pivot To Hybrid AI
  Originally published in Forbes Recently on The Dr. Data Show,...
The AI Paradox: More Humanlike Means Less Autonomous
  Originally published in Forbes The AI executives are at...
How To Overcome The Confidence-Killer That Destroys Most Predictive AI Projects
  Originally published in Forbes When Henry Castellanos first presented...
You Must Address These 4 Concerns To Deploy Predictive AI
 Originally published in Forbes Most predictive AI projects fail to launch into production. The...
SHARE THIS:

11 years ago
Video: Predictive Analytics: Advancing Precision and Population Medicine

 

This speaker session is from Predictive Analytics World for Healthcare, October, 5–9, 2014 in Boston, MA:

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.

Comments are closed.

 George Savage is the Chief Medical Officer and co-founder of Proteus Digital Health, and formerly the company’s vice president of research and development. Dr. Savage has started ten companies since 1989 as entrepreneur or founding investor, including FemRx (acquired by Johnson and Johnson), CardioRhythm (acquired by Medtronic) and QRx Pharmaceuticals (ASX IPO). Dr. Savage holds a B.S. in biomedical engineering from Boston University, where he graduated magna cum laude and Tau Beta Pi, an M.D. from Tufts University School of Medicine and an M.B.A. from Stanford University Graduate School of Business. Dr. Savage serves on the boards of

This content is restricted to site members. If you are an existing user, please log in on the right (desktop) or below (mobile). If not, register today and gain free access to original content and industry news. See the details here.